Who owns COEPTIS THERAPEUTICS HLDGS I?
- Ticker: COEP
- CUSIP Number: 19207a207
Tip: Access positions for across all investors
Analyze quarterly positions in Coeptis Therapeutics Hldgs I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Coeptis Therapeutics Hldgs I stock
Who bought or sold COEPTIS THERAPEUTICS HLDGS I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 340k | $4.8M | 570% | Dec 2025 |
|
| Vanguard Capital Management | 321k | $3.6M | 100% | Mar 2026 |
|
| Geode Capital Management | 53k | $596k | 26% | Mar 2026 |
|
| State Street Corporation | 27k | $382k | 35% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 25k | $276k | 100% | Mar 2026 |
|
| United Capital Financial Advisers | 20k | $224k | 100% | Mar 2026 |
|
| Marshall Wace | 18k | $259k | 100% | Dec 2025 |
|
| BlackRock | 14k | $152k | 0% | Mar 2026 |
|
| Northern Trust | 12k | $174k | 100% | Dec 2025 |
|
| Steward Partners Investment Advisory | 5.0k | $56k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 1.7k | $19k | 100% | Mar 2026 |
|
| Morgan Stanley | 201.00 | $2.3k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 100.00 | $1.4k | 100% | Dec 2025 |
|
| SageView Advisory Group | 3.00 | $42.999900 | 100% | Dec 2025 |
|
| Barclays | 3.00 | $42.999900 | 0% | Dec 2025 |
|
Who sold out of Coeptis Therapeutics Hldgs I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 19k | $323k |
| Pnc Financial Services | Dec 2025 | 238.00 | $3.4k |
| UBS Group | Dec 2025 | 193.00 | $2.7k |